SCHEMBL8625083

SCHEMBL8625083

N#COc1ccc(OC(=O)c2ccc(OC#N)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.52
▸ PARP10 Q53GL7 1/20 0.50
▸ PRSS1 P07477 5/20 0.49
▸ F2 P00734 3/20 0.49
▸ PRSS2 P07478 3/20 0.49
▸ PRSS3 P35030 3/20 0.49
▸ KMT2A Q03164 7/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ HGFAC Q04756 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PKM P14618 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ACR P10323 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8945658 1.00 HSD17B10 (0.52) HSD17B10PARP10PRSS1F2PRSS2
SCHEMBL30726925 0.93 PARP10 (0.49) HSD17B10PARP10PRSS1F2PRSS2
SCHEMBL11849188 0.93 PARP10 (0.57) HSD17B10PARP10PRSS1KMT2AMEN1
SCHEMBL28367645 0.91 ALDH1A1 (0.52) HSD17B10PARP10PRSS1F2PRSS2
SCHEMBL29091923 0.91 ALDH1A1 (0.52) HSD17B10PARP10PRSS1F2PRSS2
SCHEMBL28679842 0.91 KMT2A (0.59) HSD17B10PARP10KMT2AMEN1MAPT
SCHEMBL30605853 0.86 ALDH1A1 (0.51) HSD17B10PARP10PRSS1F2KMT2A
SCHEMBL25873139 0.86 PRSS1 (0.49) HSD17B10PRSS1F2PRSS2PRSS3
SCHEMBL13422364 0.84 HSD17B10 (0.39) HSD17B10PARP10PRSS1F2PRSS2
SCHEMBL9944154 0.82 CA1 (0.62) KMT2AMEN1MAPTTDP1HGFAC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0717735-B1 TRIS-(CYANATO)-S-TRIAZINES AND ANISOTROPIC DUROPLASTIC NETWORKS OBTAINED WITH THEM EUROP COMMUNITIES (LU) 1998-06-10 — — EP claimed
US-20250109222-A1 CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-03 — — US disclosed
EP-4438655-A1 CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-10-02 — — EP disclosed
CN-115175951-B Resin composition, cured product, prepreg, metal foil-clad laminate, resin sheet, and printed wiring board 三菱瓦斯化学株式会社 2024-07-12 — — CN disclosed
CN-118043384-A Prepreg, laminate and printed circuit board 三菱瓦斯化学株式会社 2024-05-14 — — CN disclosed
WO-2024090408-A1 RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD 三菱瓦斯化学株式会社 2024-05-02 — — WO disclosed
WO-2024090409-A1 RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD 三菱瓦斯化学株式会社 2024-05-02 — — WO disclosed
WO-2024090410-A1 RESIN COMPOSITION, CURED PRODUCT, PREPREG, METAL-FOIL-CLAD LAMINATE BOARD, RESIN COMPOSITE SHEET, AND PRINTED WIRING BOARD 三菱瓦斯化学株式会社 2024-05-02 — — WO disclosed
WO-2024079924-A1 RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR DEVICE 日本化薬株式会社 2024-04-18 — — WO disclosed
CN-117529509-A Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device 三菱瓦斯化学株式会社 2024-02-06 — — CN disclosed
EP-3061745-A1 CYANIC ACID ESTER COMPOUND, CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND, AND CURED PRODUCT THEREOF Mitsubishi Gas Chemical Company, Inc. (JP) 2016-08-31 — — EP disclosed
US-20160237246-A1 RESIN COMPOSITION, PREPREG, LAMINATED SHEET, AND METAL-FOIL-CLAD LAMINATED BOARD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2016-08-18 — — US disclosed
CN-105683154-A Cyanate ester compound, curable resin composition containing the same, and cured product thereof 三菱瓦斯化学株式会社 2016-06-15 — — CN disclosed
US-20160125972-A1 RESIN COMPOSITION, PREPREG, RESIN SHEET AND METAL FOIL-CLAD LAMINATE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2016-05-05 — — US disclosed
US-20160115271-A1 CYANATE ESTER COMPOUND, CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND, AND CURED PRODUCT OF SAID COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2016-04-28 — — US disclosed
EP-3012276-A1 CYANATE ESTER COMPOUND, CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND, AND CURED PRODUCT OF SAID COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2016-04-27 — — EP disclosed
EP-3012294-A1 RESIN COMPOSITION, PREPREG, RESIN SHEET AND METAL FOIL-CLAD LAMINATE Mitsubishi Gas Chemical Company, Inc. (JP) 2016-04-27 — — EP disclosed
US-20150299110-A1 METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2015-10-22 — — US disclosed
EP-2913302-A1 CYANOGEN-HALIDE PRODUCTION METHOD, CYANATE ESTER COMPOUND AND PRODUCTION METHOD THEREFOR, AND RESIN COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2015-09-02 — — EP disclosed
CN-104755422-A Method for producing cyanogen halide, cyanate ester compound and method for producing same, and resin composition MITSUBISHI GAS CHEMICAL CO 2015-07-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299110-A1 METHOD FOR PRODUCING CYANOGEN-HALIDE, CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING THE SAME, AND RESIN COMPOSITION MB, CBR3, CRYAA HSD17B10 1331/4885PARP10 395/4885PRSS1 4605/4885
US-20250109222-A1 CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE ZYX, MUS81, H1-0 HSD17B10 4508/4885PARP10 1527/4885PRSS1 3961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback